Literature DB >> 19936990

Lentivirus vectors for stably introducing genes into mammary epithelial cells in vivo.

Wen Bu1, Li Xin, Michael Toneff, Lei Li, Yi Li.   

Abstract

We have reported the use of vectors based on avian leukosis virus (ALV) and ALV env pseudotyped lentivirus for stably introducing genes into somatic mammary cells in vivo for tumor modeling. These vectors require tva transgenic mice for viral infection. Here, we report, and described the method for, stably introducing genes into the mammary gland in mice using intraductal injection of a common lentiviral vector. This method does not need tva-transgenic mice for infection. This in vivo transformation method may be useful for rapid testing of the tumorigenic potential of genes potentially involved in breast carcinogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19936990     DOI: 10.1007/s10911-009-9154-4

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  8 in total

1.  Production and purification of lentiviral vectors.

Authors:  Gustavo Tiscornia; Oded Singer; Inder M Verma
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.

Authors:  Li Xin; Michael A Teitell; Devon A Lawson; Andrew Kwon; Ingo K Mellinghoff; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 3.  RCAS-TVA in the mammary gland: an in vivo oncogene screen and a high fidelity model for breast transformation?

Authors:  Zhijun Du; Yi Li
Journal:  Cell Cycle       Date:  2007-04-22       Impact factor: 4.534

4.  Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors.

Authors:  Carlos Lois; Elizabeth J Hong; Shirley Pease; Eric J Brown; David Baltimore
Journal:  Science       Date:  2002-01-10       Impact factor: 47.728

5.  Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos.

Authors:  Alexander Pfeifer; Masahito Ikawa; Yelena Dayn; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

6.  Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.

Authors:  Zhijun Du; Katrina Podsypanina; Shixia Huang; Amanda McGrath; Michael J Toneff; Ekaterina Bogoslovskaia; Xiaomei Zhang; Ricardo C Moraes; Michele Fluck; D Craig Allred; Michael T Lewis; Harold E Varmus; Yi Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

7.  Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors.

Authors:  Stefan K Siwko; Wen Bu; Carolina Gutierrez; Brian Lewis; Martin Jechlinger; Brian Schaffhausen; Yi Li
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

Review 8.  The introduction of activated oncogenes to mammary cells in vivo using retroviral vectors: a new model for the chemoprevention of premalignant and malignant lesions of the breast.

Authors:  M N Gould
Journal:  J Cell Biochem Suppl       Date:  1993
  8 in total
  20 in total

1.  Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.

Authors:  Wen Bu; Zhenyu Liu; Weiyu Jiang; Chandandeep Nagi; Shixia Huang; Dean P Edwards; Eunji Jo; Qianxing Mo; Chad J Creighton; Susan G Hilsenbeck; Andrew D Leavitt; Michael T Lewis; Stephen T C Wong; Yi Li
Journal:  Cancer Res       Date:  2018-11-06       Impact factor: 12.701

2.  A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis.

Authors:  Vidya C Sinha; Lan Qin; Yi Li
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

3.  Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo.

Authors:  Wen Bu; Yi Li
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-11-09       Impact factor: 2.673

4.  Intraductal Delivery to the Rabbit Mammary Gland.

Authors:  Amelia Clark; Nora K Bird; Amy Brock
Journal:  J Vis Exp       Date:  2017-03-09       Impact factor: 1.355

5.  Embryonic Barcoding of Equipotent Mammary Progenitors Functionally Identifies Breast Cancer Drivers.

Authors:  Zhe Ying; Slobodan Beronja
Journal:  Cell Stem Cell       Date:  2020-02-13       Impact factor: 24.633

6.  Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation.

Authors:  Ze-Yi Zheng; Lin Tian; Wen Bu; Cheng Fan; Xia Gao; Hai Wang; Yi-Hua Liao; Yi Li; Michael T Lewis; Dean Edwards; Thomas P Zwaka; Susan G Hilsenbeck; Daniel Medina; Charles M Perou; Chad J Creighton; Xiang H-F Zhang; Eric C Chang
Journal:  Cell Rep       Date:  2015-07-09       Impact factor: 9.423

7.  Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer.

Authors:  Adelaide Young; Wen Bu; Weiyu Jiang; Amy Ku; Jyoti Kapali; Sagar Dhamne; Lan Qin; Susan G Hilsenbeck; Yi-Chieh Nancy Du; Yi Li
Journal:  Cancer Prev Res (Phila)       Date:  2021-10-19

8.  Differential regulation of c-Jun protein plays an instrumental role in chemoresistance of cancer cells.

Authors:  Yan Xia; Weiwei Yang; Wen Bu; Haitao Ji; Xueqiang Zhao; Yanhua Zheng; Xin Lin; Yi Li; Zhimin Lu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

9.  Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.

Authors:  Chunhua Song; Chandrika Gowda; Xiaokang Pan; Yali Ding; Yongqing Tong; Bi-Hua Tan; Haijun Wang; Sunil Muthusami; Zheng Ge; Mansi Sachdev; Shantu G Amin; Dhimant Desai; Krishne Gowda; Raghavendra Gowda; Gavin P Robertson; Hilde Schjerven; Markus Muschen; Kimberly J Payne; Sinisa Dovat
Journal:  Blood       Date:  2015-07-28       Impact factor: 22.113

10.  The PR status of the originating cell of ER/PR-negative mouse mammary tumors.

Authors:  J Dong; W Zhao; A Shi; M Toneff; J Lydon; D So; Y Li
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.